These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27668172)

  • 1. Barriers to clinical adoption of next generation sequencing: Perspectives of a policy Delphi panel.
    Messner DA; Al Naber J; Koay P; Cook-Deegan R; Majumder M; Javitt G; Deverka P; Dvoskin R; Bollinger J; Curnutte M; Chandrasekharan S; McGuire A
    Appl Transl Genom; 2016 Sep; 10():19-24. PubMed ID: 27668172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to clinical adoption of next-generation sequencing: a policy Delphi panel's solutions.
    Messner DA; Koay P; Al Naber J; Cook-Deegan R; Majumder M; Javitt G; Dvoskin R; Bollinger J; Curnutte M; McGuire AL
    Per Med; 2017; 14(4):339-354. PubMed ID: 29230253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
    Deverka PA; Douglas MP; Phillips KA
    Value Health; 2020 May; 23(5):540-550. PubMed ID: 32389218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utilization, Utility, and Reimbursement for Expanded Genomic Panel Testing in Adult Oncology.
    Hsiao SJ; Sireci AN; Pendrick D; Freeman C; Fernandes H; Schwartz GK; Henick BS; Mansukhani MM; Roth KA; Carvajal RD; Oberg JA
    JCO Precis Oncol; 2020 Nov; 4():1038-1048. PubMed ID: 35050771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 360-degree Delphi: addressing sociotechnical challenges of healthcare IT.
    Waldmüller H; Spreckelsen C; Rudat H; Krumm N; Rolke R; Jonas SM
    BMC Med Inform Decis Mak; 2020 Jun; 20(1):101. PubMed ID: 32503609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Private Payer and Medicare Coverage for Circulating Tumor DNA Testing: A Historical Analysis of Coverage Policies From 2015 to 2019.
    Douglas MP; Gray SW; Phillips KA
    J Natl Compr Canc Netw; 2020 Jul; 18(7):866-872. PubMed ID: 32634780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.
    Facile R; Muhlbradt EE; Gong M; Li Q; Popat V; Pétavy F; Cornet R; Ruan Y; Koide D; Saito TI; Hume S; Rockhold F; Bao W; Dubman S; Jauregui Wurst B
    JMIR Med Inform; 2022 Jan; 10(1):e30363. PubMed ID: 35084343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholders' views on the value of outcomes from clinical genetic and genomic interventions.
    Scheuner MT; Russell MM; Chanfreau-Coffinier C; Peredo J; Yano EM; Hamilton AB; Lerner B; Provenzale D; Knight SJ; Voils CI
    Genet Med; 2019 Jun; 21(6):1371-1380. PubMed ID: 30377384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Policy Challenges in Genomic Medicine.
    Klein RD
    Clin Chem; 2020 Jan; 66(1):61-67. PubMed ID: 31699701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A policy Delphi study to validate the key implications of data sharing (KIDS) framework for pediatric genomics in Canada.
    Rahimzadeh V; Bartlett G; Knoppers BM
    BMC Med Ethics; 2021 Jun; 22(1):71. PubMed ID: 34107925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
    Dy GK; Nesline MK; Papanicolau-Sengos A; DePietro P; LeVea CM; Early A; Chen H; Grand'Maison A; Boland P; Ernstoff MS; Edge S; Akers S; Opyrchal M; Chatta G; Odunsi K; Pabla S; Conroy JM; Glenn ST; DeFedericis HT; Burgher B; Andreas J; Giamo V; Qin M; Wang Y; Kanehira K; Lenzo FL; Frederick P; Lele S; Galluzzi L; Kuvshinoff B; Morrison C
    BMC Med Inform Decis Mak; 2019 Jan; 19(1):14. PubMed ID: 30658646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scenario drafting for early technology assessment of next generation sequencing in clinical oncology.
    Joosten SEP; Retèl VP; Coupé VMH; van den Heuvel MM; van Harten WH
    BMC Cancer; 2016 Feb; 16():66. PubMed ID: 26851938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay.
    Trosman JR; Van Bebber SL; Phillips KA
    J Oncol Pract; 2010 Sep; 6(5):238-42. PubMed ID: 21197187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prioritising models of healthcare service delivery for a more sustainable health system: a Delphi study of Australian health policy, clinical practice and management, academic and consumer stakeholders.
    Putrik P; Jessup R; Buchbinder R; Glasziou P; Karnon J; O Connor DA
    Aust Health Rev; 2021 Aug; 45(4):425-432. PubMed ID: 33731250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical integration of next generation sequencing: a policy analysis.
    Kaufman D; Curnutte M; McGuire AL
    J Law Med Ethics; 2014; 42 Suppl 1(Suppl 1):5-8. PubMed ID: 25298287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of payer coverage and out-of-pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings.
    Lin GA; Trosman JR; Douglas MP; Weldon CB; Scheuner MT; Kurian A; Phillips KA
    J Genet Couns; 2022 Feb; 31(1):130-139. PubMed ID: 34231930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMCP Partnership Forum: Managing Care in the Wave of Precision Medicine.
    J Manag Care Spec Pharm; 2018 Jul; 24(7):583-588. PubMed ID: 29952713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group.
    Loong HH; Shimizu T; Prawira A; Tan AC; Tran B; Day D; Tan DSP; Ting FIL; Chiu JW; Hui M; Wilson MK; Prasongsook N; Koyama T; Reungwetwattana T; Tan TJ; Heong V; Voon PJ; Park S; Tan IB; Chan SL; Tan DSW
    ESMO Open; 2023 Aug; 8(4):101586. PubMed ID: 37356359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area.
    Horgan D; Hamdi Y; Lal JA; Nyawira T; Meyer S; Kondji D; Francisco NM; De Guzman R; Paul A; Bernard B; Reddy Nallamalla K; Park WY; Triapthi V; Tripathi R; Johns A; Singh MP; Phipps ME; Dube F; Rasheed HMA; Kozaric M; Pinto JA; Doral Stefani S; Aponte Rueda ME; Fujita Alarcon R; Barrera-Saldana HA
    Healthcare (Basel); 2023 Feb; 11(3):. PubMed ID: 36767006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Content Validity of a New Patient-Reported Measure of Barriers to Antiretroviral Therapy Adherence for Electronic Administration in Routine HIV Care: Proposal for a Web-Based Delphi Study.
    Engler K; Ahmed S; Lessard D; Vicente S; Lebouché B
    JMIR Res Protoc; 2019 Aug; 8(8):e12836. PubMed ID: 31376275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.